ReP USP - Resultado da busca

Feasibility of therapeutic 1131 metaiodobenzylguanidine (MIBG) previous to blood stem cell, collection as "purging in vivo" for high-risk neuroblastomas (HRNB) (2014)

Odone Filho, Vicente; Almeida, M. T. A.; Buchpiguel, C.; Azambuja, A. M. P.; Vince, C. S. C.; Brumatti, M.; Neves, N. S. H.; Batista, G. L. F.; Maluf Junior, P. T.; Cristofani, L. M. C.

Source: Pediatric Blood Cancer. Conference titles: Congress of the International Society of Paediatric Oncology. Unidade: FM

Subjects: NEUROBLASTOMA, CRIANÇAS, CINTILOGRAFIA

A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

ABNT
ODONE FILHO, Vicente et al. Feasibility of therapeutic 1131 metaiodobenzylguanidine (MIBG) previous to blood stem cell, collection as "purging in vivo" for high-risk neuroblastomas (HRNB). 2014, Anais.. Hoboken: Faculdade de Medicina, Universidade de São Paulo, 2014. p. S207. Disponível em: http://onlinelibrary.wiley.com/doi/10.1002/pbc.25314/pdf. Acesso em: 24 ago. 2024.
APA
Odone Filho, V., Almeida, M. T. A., Buchpiguel, C., Azambuja, A. M. P., Vince, C. S. C., Brumatti, M., et al. (2014). Feasibility of therapeutic 1131 metaiodobenzylguanidine (MIBG) previous to blood stem cell, collection as "purging in vivo" for high-risk neuroblastomas (HRNB). In Pediatric Blood Cancer (Vol. 61, p. S207). Hoboken: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://onlinelibrary.wiley.com/doi/10.1002/pbc.25314/pdf
NLM
Odone Filho V, Almeida MTA, Buchpiguel C, Azambuja AMP, Vince CSC, Brumatti M, Neves NSH, Batista GLF, Maluf Junior PT, Cristofani LMC. Feasibility of therapeutic 1131 metaiodobenzylguanidine (MIBG) previous to blood stem cell, collection as "purging in vivo" for high-risk neuroblastomas (HRNB) [Internet]. Pediatric Blood Cancer. 2014 ; 61( S2): S207.[citado 2024 ago. 24 ] Available from: http://onlinelibrary.wiley.com/doi/10.1002/pbc.25314/pdf
Vancouver
Odone Filho V, Almeida MTA, Buchpiguel C, Azambuja AMP, Vince CSC, Brumatti M, Neves NSH, Batista GLF, Maluf Junior PT, Cristofani LMC. Feasibility of therapeutic 1131 metaiodobenzylguanidine (MIBG) previous to blood stem cell, collection as "purging in vivo" for high-risk neuroblastomas (HRNB) [Internet]. Pediatric Blood Cancer. 2014 ; 61( S2): S207.[citado 2024 ago. 24 ] Available from: http://onlinelibrary.wiley.com/doi/10.1002/pbc.25314/pdf

Abdominal recurrence of meduloblastoma (medullo): prolonged disease-free survival after autologous (periheral blood (PB) and bone marrow (BM)) transplantation (ABMT) (1999)

Odone Filho, Vicente; Cristófani, L. M.; Almeida, M. T. A.; Machado, T. M.; Maluf Junior, P. T.; Moura, J. M.; Broniscor, A.

Conference titles: Tandem BMT Meetings. Unidade: FM

Assunto: PEDIATRIA

USP Schools

ReP

Filtros

Authors